Using the ultimate disease model: the Human, the Human Immunobiology and Pathogenesis Lab aims at understanding tissue- and cell-specific factors controlling the induction of protective versus pathogenic immunity throughout human life, from in-uterus to the elderly.
Studies in inbred animals have proven indispensable for unravelling the molecular underpinnings of the immune system. We have made less progress, however, in understanding the workings of the human immune system. All too often, animal models fail to faithfully recapitulate all the facets of human disease, and therapies that work well in preclinical models fail to show efficacy in human trials.
A particular area of interest consists in determining the key factors driving the sex-bias in immune responses. Central to our research is the molecular access to human tissues and a mechanism-driven development of biologicals at the interface of immunology, clinical research and biotechnology. We have partnership agreements with 8 other institutions, including research centers, as well as 5 hospitals and Gilead and Pfizer Pharma support. In the last 5 years, our group has secured national and european funding and high impact publications.
Pursuant to the provisions of article 11, paragraph 2, of Decree-Law no. 57/2016, of August 29, it becomes public that by Dean’s decree of May 17, 2022, the opening of an international selection competition procedure was authorized for the completion of a PhD holder job vacancy for the exercise of scientific research activities in the scope of the project LISBOA-01-0145-FEDER-029520, funding granted by the Programa Operacional Regional de Lisboa supported by the FEDER and by national funds, through the Fundação para a Ciência e Tecnologia, I.P. (FCT, I.P), under an uncertain fixed-term employment contract under the Labor Code in the Faculdade de Ciências Médicas|NOVA Medical School from Universidade NOVA de Lisboa.
Application deadline: June 29, 2022 (until 30/06/2022 00:00)
A joint effort between 3 Portuguese institutes, including CEDOC-NMS School, warns of 2 mutations in SARSCoV2 spike protein that could elude the immune system.
A brand new study regarding the transference of COVID-19 immunity from breast milk to newborns was just published in Cell Reports Medicine, led by Helena Soares lab, Immunobiology and Pathogenesis, along with partners in ITQB NOVA and IGC.
NOVA Medical School will be present at Ciência 2022, the largest meeting of Science and Technology in Portugal, with full representation of its research with its four Research Units and three Associate Laboratories, during for the entire duration of the event at Centro de Congressos de Lisboa.
Collaborations with Hospitals (public and private)
Collaborations within NMS:
Collaborations outside CEDOC|NMS:
NOVA Medical SchoolCampo Mártires da Pátria, 1301169-056 LisboaPORTUGAL
GeneralTel.: +351 218 803 000
Compliment, suggestion or complaint
News and Events
Awards and Honours